Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia

BACKGROUND: Cefiderocol is a novel siderophore cephalosporin, developed for activity against MDR Gram-negative bacilli (MDR-GNB). OBJECTIVES: To assess the in vitro antibacterial activity of cefiderocol against a collection of MDR-GNB clinical isolates from hospitals in southern Spain. METHODS: Two...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgado-Valverde, Mercedes, Conejo, M del Carmen, Serrano, Lara, Fernández-Cuenca, Felipe, Pascual, Álvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303814/
https://www.ncbi.nlm.nih.gov/pubmed/32277821
http://dx.doi.org/10.1093/jac/dkaa117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303814/
https://www.ncbi.nlm.nih.gov/pubmed/32277821
http://dx.doi.org/10.1093/jac/dkaa117

Ejemplares similares